Page 4 - CANNABIDIOL (CBD) Critical Review Report Geneva, 4-7 June 2018 World Health Organization
P. 4
Cannabidiol (CBD)
16. Illicit Manufacture and Traffic and Related Information................................................. 20
17. Current International Controls and Their Impact ............................................................. 20
18. Current and Past National Controls ................................................................................... 21
19. Other Medical and Scientific Matters Relevant for a Recommendation on the Scheduling
of the Substance................................................................................................................... 21
References ............................................................................................................................................ 22
3